Publication search
with syndrome de sevrage as keyword
Lodge, Andrew Partyka, Chantelle Surbey, Kelly
Published in
Canadian Journal of Public Health = Revue Canadienne de Santé Publique
Setting Substance use remains a pervasive public health issue throughout Canada, exerting substantial economic, social, and political pressure on health care systems, while impacting lives of affected individuals. The advent of COVID-19 has been doubly perilous; it restricts existing programming, while exacting a worsening toll on mental health and...
Karila, Laurent Lafaye, Geneviève Coscas, Sarah Blecha, Lisa Benyamina, Amine
Le cannabis reste la drogue la plus expérimentée au cours de la vie et la plus consommée en France notamment chez les adolescents, les jeunes adultes et les populations souffrant de troubles psychiatriques (schizophrénie, trouble anxieux, trouble dépressif, trouble bipolaire...). Cette substance se consomme essentiellement par voie inhalée ma...
J. Koch, Horst
Published in
Thérapie
A 65-year old patient suffering from severe psychotic depression obtained quetiapine for roughly one year. Several attempts to discontinue quetiapine by tapering the dose provoked severe withdrawal symptoms with nausea and vomitus. Pretreatment with domperidone largely prevented withdrawal so that he finally could successfully discontinue quetiapin...
Gourarier, Laurent Aubisson, Sandrine Cneude, Francis Piquet, Martine Peyret, Emmanuelle Simmat-Durand, Laurence Lejeune, Claude
Previous results from our team have shown that opiate dependent women who received substitution during pregnancy and early post partum period had rather similar results on birth, neonatal withdrawal syndrome (NWS) and perinatal patterns of the infant, whether they received oral methadone or sublingual buprenorphine treatment. Despite few difference...
